Abstract
Abstract In goitre prevention assays in adult female rats, thyroxine was only one-fifth to one-sixth as active by mouth as by subcutaneous injection whereas liothyronine had about the same biological activity for the two routes of administration. These findings provide an explanation for the fact that thyroxine was one-sixth to one-seventh as active as liothyronine when injected subcutaneously but only one-twentieth to one-thirtieth as potent when the hormones were administered orally. Chemical examination of three commercially available thyroxine samples which were labelled as “chromatographically pure” revealed that one of them contained approximately 10 per cent liothyronine. The presence of this contaminant had a marked influence on the biological responses of the test animals to this preparation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
